Skip to content

Efficacy of dexmedetomidine combined with lidocaine infusion in thyroidectomy

Efficacy of dexmedetomidine combined with lidocaine infusion in thyroidectomy

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900025761
Enrollment
Unknown
Registered
2019-09-07
Start date
2019-09-16
Completion date
Unknown
Last updated
2019-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

clinical anesthesia

Interventions

group 2:dexmedetomidine 0.5ug/kg
group 3:lidocaine+dexmedetomidine 0.5ug/kg
group 4:control

Sponsors

Shiyan People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: The American Society of Anesthesiologists (ASA) physical status I and II; aged between 18 to 60 years; BMI 18-25 kg/m2; Patients undergoing elective thyroidectomy in general anesthesia.

Exclusion criteria

Exclusion criteria: 1. Patients with heart, brain, lung, liver, kidney and other major organ diseases; 2. Allergic to dexmedetomidine, lidocaine and other experimental drugs; 3. Recent users of beta blockers and alpha 2 agonists; 4. Alcohol and drug abusers; 5. Long-term users of sedatives, analgesics and long-term alcoholics; 6. Patients with a history of mental illness, language communication disorder and inability to understand the experiment content.

Design outcomes

Primary

MeasureTime frame
cytokines;

Secondary

MeasureTime frame
Consumption of propofol;postoperative pain;Postoperative recovery quality;patient satisfaction;Postoperative incidence of nausea and vomiting;Postoperative intestinal function recovery time;

Countries

China

Contacts

Public ContactRan Ran

Shiyan people's hospital affiliated to Hubei University of Medicine

18671910918@163.com+86 18671910918

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026